ALK and adenocarcinoma: FISH analysis confirmed the presence of ALK gene rearrangement in only sevenpatients (4.8% of all patients, 20.7% of RT-PCR positive patients) including six patients with adenocarcinoma (7.5%; 6/80) and single patient with adenosquamous carcinoma [15].